Impairment of heart rate variability during paclitaxel therapy

Cancer

Volumn 88, Issue 9, 2000, Pages 2149-2153

  Ekholm, Eeva M K ^a   Salminen, Eeva K ^a   Huikuri, Heikki V ^b   Jalonen, Jarmo ^a   Antila, Kari J ^a   Salmi, Tuula A ^a   Rantanen, Virpi T ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Autonomic nervous system; Chemotherapy; Heart rate variability; Paclitaxel

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PACLITAXEL;

ADULT; AGED; ARTICLE; AUTONOMIC INNERVATION; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CARDIOVASCULAR AUTOREGULATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; OVARY CARCINOMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTONOMIC NERVOUS SYSTEM; BREAST NEOPLASMS; CARCINOMA; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; RISK FACTORS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 0342749289     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000501)88:9<2149::AID-CNCR22>3.0.CO;2-Z     Document Type: Article

References (29)

1. McGuire WE, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
2. Clemons M, Leahy M, Valle I, Jayson G, Ranson M, Howell A. Review of recent trials of chemotherapy for advanced breast cancer: the Taxanes. Eur J Cancer 1997;33:2183-93.
3. Bisset D, Kaye SB. Taxol and taxotere - current status and future prospects. Eur J Cancer 1993;29A:1228-31.
4. Hochster H, Wasserheit C, Speyer J. Cardiotoxicity and cardioprotection in chemotherapy. Curr Opin Oncol 1995;7: 304-9.
5. McGuire WP, Rowinsky EK, Rosenshein NB. Taxol: a new antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Int Med 1989;111:273-9.
6. Rowinsky EK, McGuire WP, Guarneri T, Fisherman JS, Christian MC, Donehower RC. Cardiac disturbances during the administration of Taxol. J Clin Oncol 1991;9:1704-12.
7. Alagaratnam TT. Sudden death 7 days after paclitaxel infusion for breast cancer. Lancet 1993;342:1232-3.
8. Jekunen A, Heikkilä P, Maiche A, Pyrhönen S. Paclitaxel-induced myocardial damage detected by electron microscopy. Lancet 1994;343:727-8.
9. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Multicenter post-infarction research group: decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-62.
10. Huikuri HV, Koistinen MJ, Yli-Mäyry S, Airaksinen KEJ, Seppänen T, Ikäheimo MJ, et al. Impaired low-frequency oscillations of heart rate in patients with prior acute myocardial infarction and life-threatening arrhythmias. Am J Cardiol 1995;76:56-60.
11. Huikuri HV, Valkama JO, Airaksinen KEJ, Seppänen T, Kessler KM, Takkunen JT, et al. Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease. Circulation 1993;87:1220-8.
12. Huikuri HV, Niemelä MJ, Ojala S, Rantala A, Ikäheimo MJ, Airaksinen KEJ. Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease. Effects of arousal and upright posture. Circulation 1993;90:121-6.
13. Chakko S, Mulingtapang RF, Huikuri HV, Kessler KM, Materson BJ, Myerburg RJ. Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease. Am Heart J 1993;126:1364-72.
14. Bernardi L, Ricordi L, Lazzari P, Solda P, Calciati A, Ferrari MR, et al. Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation 1992;86: 1443-52.
15. Wheeler T, Watkins PJ. Cardiac denervation in diabetes. Br Med J 1973;4:584-6.
16. Hirvonen H, Salmi TT, Heinonen E, Antila KJ, Välimäki IAT. Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy. Cancer 1989; 64:801-5.
17. Roca E, Bruera E, Politi PM, Barugel M, Cedaro L, Carraro S, et al. Vinca alkaloid-induced cardiovascular autonomic neuropathy. Cancer Treat Rep 1985;69:149-51.
18. Viniegra M, Marchetti M, Losso M, Navigante A, Litovska S, Senderowicz A, et al. Cardiovascular autonomic function in anthracycline-treated breast cancer patients. Cancer Chemother Pharmacol 1990;26:227-31.
19. Huikuri HV, Kessler KM, Terracall E, Castellanos A, Linnaloto MK, Myerburg RJ. Reproducibility and circadian rhythm of heart rate variability in healthy subjects. Am J Cardiol 1990;65:391-3.
20. Ekholm E, Rantanen V, Antila K, Salminen E. Paclitaxel changes sympathetic control of blood pressure. Eur J Cancer 1997;33:1419-24.
21. Huikuri HV, Linnaluoto MK, Seppänen T, Airaksinen KEJ, Kessler KM, Takkunen JT, et al. Circadian rhythm of heart rate variability in survivors of cardiac arrest. Am J Cardiol 1992;70:610-5.
22. Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol 1985;249:H867-75.
23. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-93.
24. Bigger JTJ, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-71.
25. Odemuyiwa O, Malik M, Farrell T, Bashir Y, Poloniecki J, Camm J. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991; 68:434-9.
26. Van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997;95:1449-54.
27. Bendini MG, Intini A, Corvo P, De Martino A, Maseri A, Lanza GA. Heart rate variability as prognostic tool for cardiac events in patients with idiopathic dilated cardiomyopathy. Eur Heart J 1997;18:409.
28. Biadi O, Mengozzi G, Gherarducci G, Strata G, Mariani M, Baldini F, et al. Evaluation of Taxol cardiotoxicity in metastatic breast cancer. Ann NY Acad Sci 1993;698:403-5.
29. Shek TWH, Luk ISC, Ma L, Cheung KL. Paclitaxel-induced cardiotoxicity. An ultrastructural study. Arch Pathol Lab Med 1996;120:89-91.